12:00 AM
 | 
Oct 22, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Turoctocog alfa regulatory update

Novo Nordisk submitted an NDA to FDA and an MAA to EMA for turoctocog alfa to prevent and treat...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >